Abstract: This invention relates to chemical compositions comprising two thickening components, which are sclerotium gum and a copolymer selected from the group consisting of methyl vinyl ether/maleic anhydride copolymer and acryloyldimethyltaurate vinylpyrrolidone copolymer, in particular the ammonium salt of the latter; which components provide good thickening properties in the presence of electrolytes, in particular in the presence of ethanolamine or vitamin salts. Further there are provided cosmetic formulations comprising these thickening components.
Type:
Grant
Filed:
September 30, 2003
Date of Patent:
January 28, 2014
Assignee:
Johnson & Johnson Consumer France SAS
Inventors:
Muriel Morelli, Agnes Le Fur, Carole Dupressoir
Abstract: The present invention relates to a composition including at least one retinoid and at least one beta-aminoisobutyric acid derivative and the use thereof for the preparation of an article to be used for the topical application to skin, hair or nails.
Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of ?-unsaturated ?-lactone.
Type:
Grant
Filed:
June 16, 2005
Date of Patent:
June 17, 2008
Assignee:
Johnson & Johnson Consumer France, SAS, Roc Division
Inventors:
Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
Abstract: This invention relates to formulations containing a combination of anisic acid, or a salt thereof, or an ester thereof, and a C6-14 fatty acid monoglyceride and to the use of such combinations as a preservative system.
Type:
Grant
Filed:
December 13, 2004
Date of Patent:
August 28, 2007
Assignee:
Johnson & Johnson Consumer France SAS
Inventors:
Florence Baranger, Jean Francois Porracchia
Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of ?-unsaturated ?-lactone.
Type:
Grant
Filed:
November 25, 2003
Date of Patent:
June 12, 2007
Assignee:
Johnson & Johnson Consumer France SAS
Inventors:
Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of &agr;-unsaturated &ggr;-lactone.
Type:
Grant
Filed:
June 2, 2000
Date of Patent:
June 25, 2002
Assignee:
Johnson & Johnson Consumer France SAS I3540
Inventors:
Theresa Callaghan, Thierry Oddos, Gerard Gendimenico, Katharine Martin
Abstract: The present invention relates to the use of at least two compounds chosen from components having an a) anti-radical, b) anti-inflammatory and c) anti-allergic activity for the preparation of a composition exhibiting at least two of the a), b) and c) activities intended for the treatment of sensitive and/or allergic skin. It also relates to a process for the preparation of such compositions and to the compositions thus obtained.
Type:
Grant
Filed:
April 16, 1999
Date of Patent:
March 5, 2002
Assignee:
Johnson & Johnson Consumer France, SAS, ROC
Division